We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Celltrion Files Challenges to Four of Genentech’s Herceptin Patents
Celltrion Files Challenges to Four of Genentech’s Herceptin Patents
South Korean biosimilars firm Celltrion is challenging the validity of four Genentech patents for combination therapies to treat metastatic breast cancer.
